Urban health in developing countries: What do we know and where do we go?

被引：164
|
作者：
Harpham, Trudy [1 ,2 ]
机构：
[1] London S Bank Univ, London SE1 0AU, England
[2] London Sch Hyg & Trop Med, London, England
来源：
HEALTH & PLACE | 2009年 / 15卷 / 01期
基金：
英国医学研究理事会;
关键词：
Urban; Developing countries; Review; Intra-urban differences; Resilience; Social determinants; CHALLENGES; POVERTY; CALI;
D O I：
10.1016/j.healthplace.2008.03.004
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The world became mainly urban in 2007. It is thus timely to review the state of knowledge about urban health and the current priorities for research and action. This article considers both health determinants and outcomes in low-income urban areas of developing countries. The need to study urban health in a multi-level and multi-sectoral way is highlighted and priorities for research are identified. Interventions such as the Healthy Cities project are considered and obstacles to the effective implementation of urban health programmes are discussed. Concepts such as the double burden of ill health and the urban penalty are re-visited. Finally, a call for a shift from 'vulnerability' to 'resilience' is presented. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：107 / 116
页数：10
相关论文
共 50 条
  • [41] Patient-focused and feedback research in psychotherapy: Where are we and where do we want to go?
    Lutz, Wolfgang
    De Jong, Kim
    Rubel, Julian
    PSYCHOTHERAPY RESEARCH, 2015, 25 (06) : 625 - 632
  • [42] Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence
    Holloway, K. A.
    Ivanovska, V.
    Wagner, A. K.
    Vialle-Valentin, C.
    Ross-Degnan, D.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 (06) : 656 - 664
  • [43] High-sensitivity troponin: where are we now and where do we go from here?
    Korley, Frederick K.
    Jaffe, Allan S.
    BIOMARKERS IN MEDICINE, 2014, 8 (08) : 1021 - 1032
  • [44] Information technology to support patient engagement: where do we stand and where can we go?
    Walker, Daniel M.
    Sieck, Cynthia J.
    Menser, Terri
    Huerta, Timothy R.
    McAlearney, Ann Scheck
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2017, 24 (06) : 1088 - 1094
  • [45] PICU SERVICES IN DEVELOPING COUNTRIES, WHERE WE ARE? WHERE SHOULD WE GO FROM HERE? SUDAN EXPERIENCES
    Juma, B.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [46] Strategic Messaging to Promote Policies that Advance Racial Equity: What Do We Know, and What Do We Need to Learn?
    Niederdeppe, Jeff
    Liu, Jiawei
    Spruill, Mikaela
    Lewis, Neil A. A.
    Moore, Steven
    Fowler, Erika Franklin
    Gollust, Sarah E.
    MILBANK QUARTERLY, 2023, 101 (02) : 349 - 425
  • [47] Cancer education for medical students in developing countries: Where do we stand and how to improve?
    Amgad, Mohamed
    Shash, Emad
    Gaafar, Rabab
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 122 - 129
  • [48] A Methodological Review of Employee Creativity (2014-2018): Where are We and Where do We Want to Go?
    Pribadi, Jeliteng
    2019 AIB SOUTHEAST ASIA REGIONAL CONFERENCE: US-CHINA TRADE WAR, DEGLOBALIZATION, AND INTERNATIONAL BUSINESS (AIBSEAR), 2019, : 750 - 802
  • [49] Health insurance in India: what do we know and why is ethnographic research needed
    Ahlin, Tanja
    Nichter, Mark
    Pillai, Gopukrishnan
    ANTHROPOLOGY & MEDICINE, 2016, 23 (01) : 102 - 124
  • [50] Malignant Priapism-What Do We Know About It?
    Marcu, Dragos
    Iorga, Lucian
    Mischianu, Dan
    Bacalbasa, Nicolae
    Balescu, Irina
    Bratu, Ovidiu
    IN VIVO, 2020, 34 (05): : 2225 - 2232
12345